Clinical trial
A Study of Long-term Treatment With Deferasirox in Patients With…
NCT00171171 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00171171 |
|---|---|
| Title | A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis |
| Official title | A Study of Efficacy and Safety of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Beta-Thalassemia, Hemosiderosis |
| Intervention type | Drug |
| Interventions | deferasirox |
| Enrollment | 252 |
| Start date | May 1, 2004 |
| Primary completion | Nov 1, 2006 |
| First posted | Sep 15, 2005 |
| Last update posted | Mar 1, 2017 |
| Countries | Egypt, Lebanon, Oman, Saudi Arabia, Syria |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: